Cargando…

Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis

BACKGROUND: The goal was to determine whether one medical centres’ unique antifungal prophylactic regimen for patients at high risk for invasive candidiasis because of their haematological malignancies, haematopoietic stem cell transplants, or high-dose chemotherapy might lead ultimately to a higher...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vuichard, Danielle, Weisser, Maja, Orasch, Christina, Frei, Reno, Heim, Dominik, Passweg, Jakob R, Widmer, Andreas F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233028/ https://www.ncbi.nlm.nih.gov/pubmed/25384689 http://dx.doi.org/10.1186/s12879-014-0573-5

Ejemplares similares

Fluconazole prophylaxis for prevention of invasive candidiasis in extremely preterm infants
por: Kim, Chun Soo
Publicado: (2020)

Actinobaculum schaalii - invasive pathogen or innocent bystander? A retrospective observational study
por: Tschudin-Sutter, Sarah, et al.
Publicado: (2011)

Is switching to an oral antibiotic regimen safe after 2 weeks of intravenous treatment for primary bacterial vertebral osteomyelitis?
por: Babouee Flury, Baharak, et al.
Publicado: (2014)

Comparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal Candidiasis
por: Nouraei, S., et al.
Publicado: (2012)

Bioadhesive Films Containing Fluconazole for Mucocutaneous Candidiasis
por: Patel, S. K., et al.
Publicado: (2015)

Corrigendum to “Comparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal Candidiasis”
por: Nouraei, S., et al.
Publicado: (2017)

Fluconazole prophylaxis against invasive candidiasis in very low and extremely low birth weight preterm neonates: a systematic review and meta-analysis
por: Robati Anaraki, Mahmoud, et al.
Publicado: (2020)

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
por: Gebretekle, Gebremedhin Beedemariam, et al.
Publicado: (2022)

Comparative evaluation of fluconazole and clotrimazole in treatment of oral candidiasis
por: Madane, Pragati C, et al.
Publicado: (2022)

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
por: Kett, Daniel H, et al.
Publicado: (2011)

Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients
por: Grau, S, et al.
Publicado: (2015)

Preparation and Characterisation of Fluconazole Vaginal Films for the Treatment of Vaginal Candidiasis
por: Kumar, L., et al.
Publicado: (2013)

Sphingolipid Inhibitors as an Alternative to Treat Candidiasis Caused by Fluconazole-Resistant Strains
por: Rollin-Pinheiro, Rodrigo, et al.
Publicado: (2021)

Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
por: Wiederhold, Nathan P, et al.
Publicado: (2009)

Comparative Study of the Effectiveness of Oral Fluconazole and Intravaginal Clotrimazole in the Treatment of Vaginal Candidiasis
por: Mikamo, Hiroshige, et al.
Publicado: (1995)

The effect of fluconazole treatment on tumor necrosis factor-alpha production in murine candidiasis.
por: Kalkanci, Ayse, et al.
Publicado: (2002)

Nosocomial candidiasis in Rio de Janeiro State: Distribution and fluconazole susceptibility profile
por: Neufeld, Paulo Murillo, et al.
Publicado: (2015)

Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis
por: Nyirjesy, Paul, et al.
Publicado: (2021)

Comparison of the antifungal effect of voriconazole and fluconazole on oral candidiasis before and during radiotherapy
por: Golestannejad, Zahra, et al.
Publicado: (2022)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin - review of the literature
por: Glöckner, A
Publicado: (2011)

A pseudo-randomised clinical trial of in situ gels of fluconazole for the treatment of oropharngeal candidiasis
por: Nairy, Harish M, et al.
Publicado: (2011)

Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis
por: Gonzalez, Javier M., et al.
Publicado: (2015)

Assessment of Effectiveness of Fluconazole and Clotrimazole in Treating Oral Candidiasis Patients: A Comparative Study
por: Reddy, R. C. Jagat, et al.
Publicado: (2017)

Fluconazole prophylaxis in preterm infants: a systematic review
por: Rios, Juliana Ferreira da Silva, et al.
Publicado: (2017)

Updates in the Pharmacologic Prophylaxis and Treatment of Invasive Candidiasis in the Pediatric and Neonatal Intensive Care Units: Updates in the Pharmacologic Prophylaxis
por: Fly, James Hunter, et al.
Publicado: (2022)

Timing of Cefuroxime Surgical Antimicrobial Prophylaxis and Its Association With Surgical Site Infections
por: Sommerstein, Rami, et al.
Publicado: (2023)

Association Between Antimicrobial Prophylaxis With Double-Dose Cefuroxime and Surgical Site Infections in Patients Weighing 80 kg or More
por: Sommerstein, Rami, et al.
Publicado: (2021)

Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis
por: Rençber, Seda, et al.
Publicado: (2016)

Fluconazole and echinocandin resistance of Candida species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak
por: Szekely, Jidapa, et al.
Publicado: (2023)

Coadministration of Ginger Extract and Fluconazole Shows a Synergistic Effect in the Treatment of Drug-Resistant Vulvovaginal Candidiasis
por: Khan, Arif, et al.
Publicado: (2021)

2446. Effect of the Implementation of a Fluconazole Prophylaxis Protocol on the Incidence of Invasive Fungal Infection in High-Risk Neonates
por: Isada, Patricia Marie D, et al.
Publicado: (2023)

Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia
por: Döring, M., et al.
Publicado: (2015)

Dynamics of ampicillin-resistant Enterococcus faecium clones colonizing hospitalized patients: data from a prospective observational study
por: Weisser, Maja, et al.
Publicado: (2012)

Performance of the T2Candida Panel for the Diagnosis of Intra-abdominal Candidiasis
por: Lamoth, Frederic, et al.
Publicado: (2020)

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
por: Reboli, Annette C, et al.
Publicado: (2011)

Antimicrobial Photodynamic Therapy in Combination with Nystatin in the Treatment of Experimental Oral Candidiasis Induced by Candida albicans Resistant to Fluconazole
por: Janeth Rimachi Hidalgo, Karem, et al.
Publicado: (2019)

Comparing the Effect of Probiotic and Fluconazole on Treatment and Recurrence of Vulvovaginal Candidiasis: a Triple-Blinded Randomized Controlled Trial
por: Mollazadeh-Narestan, Zahra, et al.
Publicado: (2022)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs - review of the literature
por: Wilke, MH
Publicado: (2011)

635. Is Azole Prophylaxis in Liver Transplant Recipients Effective in Preventing Invasive Candidiasis in the Era of Emerging Resistance?
por: Gurram, Pooja R, et al.
Publicado: (2022)

Overexpression of MDR-1 and CDR-2 genes in fluconazole resistance of Candida albicans isolated from patients with vulvovaginal candidiasis
por: Khosravi Rad, K, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_41fb07ehfndkq0pes3qfvdqloh